학술논문
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial
Document Type
Article
Author
Cools, F.; Virdone, S.; Kayani, G.; Pieper, K.; Kakkar, A.K.; Sawhney, J.; Lopes, R.D.; Jacobson, B.; Arcelus, J.I.; Hobbs, F.D.R.; Gibbs, H.; Himmelreich, J.C.L.; MacCallum, P.; Schellong, S.; Haas, S.; Turpie, A.G.G.; Ageno, W.; Rocha, A.T.; Avhad, A.; Antunes, M.; Thereza Rocha, A.; Gonzales Lama, J.; Abyankar, A.; Kormann, A.P.M.; Van Zyl, L.; Kaul, U.; Adams, F.; Aloysius, I.; Capehorn, M.; Kumar, P.; Mahajan, R.
Source
In: The Lancet Haematology . (The Lancet Haematology, August 2022, 9(8):e594-e604)
Subject
Language
English
ISSN
23523026